Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement — Abbott Molecular, Inc. (PMA P110012)

Name: Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement — Abbott Molecular, Inc. (PMA P110012)
Creator: DeviceClear

Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement — Abbott Molecular, Inc. (PMA P110012) is one of 9,000 device clearances in the DeviceClear dataset. Key details — Device name: Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement; Applicant: Abbott Molecul

Device name	Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
Applicant	Abbott Molecular, Inc.
Clearance track	PMA
Submission number	P110012
Decision	APPR
Decision date	2020-05-22
Date received	2019-12-23
Product code	OWE
Device class	3
Medical specialty	Unknown
Applicant location	IL
Source	openFDA device

🔍 Search all device clearances →

$1999/mo

Try DeviceClear →